ArticleBMJ case reports2018

Minimal change disease with maximum immunosuppression: successful treatment of steroid-dependent minimal change disease with rituximab.

Helena Pinto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.